Allovir, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ALVR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1100 Winter Street, Waltham, MA

Insiders trading volume in the past year

Allovir, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morana Jovan-Embiricos Director, 10%+ Owner $21.1M Jun 6, 2024
David Hallal Director, 10%+ Owner $15.6M Jun 6, 2024
Ansbert Gadicke Director, 10%+ Owner $11.2M Jul 28, 2022
ElevateBio, LLC Director, 10%+ Owner $11.2M Jul 28, 2022
Gilead Sciences, Inc. 10%+ Owner $11.2M Jun 27, 2023
Vikas Sinha Officer Title: President and Chief Financial Officer, Director, 10%+ Owner $9.77M -$45.6K -0.46% Nov 19, 2024
F2 MG Ltd Director, 10%+ Owner $6.59M Jul 28, 2022
John Robert Wilson Director $2.12M May 25, 2021
Juan Vera Director $1.91M Jun 6, 2024
Diana Brainard Chief Executive Officer, Director $397K -$109K -21.6% Nov 19, 2024
Agustin Melian Chief Medical Officer $304K Oct 4, 2021
Edward Miller General Counsel $274K -$17.8K -6.08% Dec 11, 2024
Jeroen B. Van Beek Chief Commercial Officer $224K Nov 16, 2022
Malcolm Brenner Director $209K Jun 6, 2024
Cintia Piccina Chief Commercial Officer $98.6K Jul 3, 2023
Ercem Atillasoy Officer $88.1K Oct 20, 2022
Jeffrey Bornstein Director $87.3K Jun 6, 2024
Ann M. Leen Chief Scientific Officer $83.2K Aug 16, 2022
Shawn Tomasello Director $55.5K Jun 6, 2024
Derek N. Adams Director $55.5K Jun 6, 2024
Brett Hagen Chief Accounting Officer $37.6K -$41.3K -52.4% Nov 19, 2024

Recent Insider Transactions by Companies or Individuals for Allovir, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.